Navigation Links
NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis

United States. As in the 111 study,

patients will be 40 years, or older, with osteoarthritis in at least

one hip or knee and a diagnosis of controlled essential hypertension.

Following a one week screening period, patients will be randomized to

either one of five groups, which will receive 13 weeks of treatment

with: naproxcinod 375 mg bid (twice-daily), naproxcinod 750 mg bid,

naproxen 250 mg bid, naproxen 500 mg bid or ibuprofen 600 mg tid. At

the end of the treatment period, all patients will receive placebo for

2 weeks. 24-hour blood pressure monitoring will be conducted at

baseline and at the end of the 13-week treatment period. The primary

objective of the study is to assess the mean change from baseline in

the average 24-hour systolic blood pressure, as well as evaluating the

general safety and tolerability of naproxcinod.

Staffan Stromberg, Vice President of Drug Development at NicOx, said: "We have chosen naproxen as the comparator in the pivotal phase 3 studies, due to its well established anti-inflammatory efficacy and its perception as the least risky of the existing NSAIDs in terms of blood pressure and cardiovascular safety. In the 112 study, we will also obtain long term 24-hour blood pressure comparisons between our first CINOD and ibuprofen, the most widely used NSAID."

NOTE 1: The biological mechanisms by which NSAIDs increase blood pressure are not well understood, although an increase in blood vessel constriction, interference with antihypertensive treatment and retaining dietary salt all seem to contribute. The extent of the increase is not fully defined, although there appears to be a variation between different products, with ibuprofen and the selective COX-2 inhibitors bringing about greater increases than non- selective drugs, such as naproxen. However, all existing products have been associated with some bloo

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
2. NicOx Opens U.S. Headquarters in New Jersey
3. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
4. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
5. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
6. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
7. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
8. Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis
9. Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
10. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
11. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
Post Your Comments:
(Date:8/1/2014)... Chantel Lee ’15 and Eli Capello ’15 sacrificed a ... Dr. Juan Rodriguez, Professor of Physics, in an effort to ... disease caused by changes in the blood vessels of the ... quite remarkable,” said Rodriguez. “They took on a graduate level ... together carried it to near completion in just a few ...
(Date:8/1/2014)... CHICAGO , Aug. 1. 2014 As ... U.S., the 2014 AACC Annual Meeting & Clinical Lab ... testing and patient care are introduced to the healthcare ... by the Expo,s 650 exhibitors will include the latest ... Advances in smartphones and biosensors have enabled ...
(Date:8/1/2014)... 2014 Research and Markets has ... Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" report ... Single Nucleotide Polymorphism (SNP) genotyping is ... in the genome of various species. SNPs are commonly ... analysis technology can analyze thousands of SNPs and has ...
(Date:8/1/2014)... 01, 2014 Testing the mechanical ... a better understanding embryonic development. How and ... structurally and functionally distinct tissues is important because ... Prof. Todd McDevitt, Melissa Kinney, and Rabbia Saeed ... with biochemical cues to control many aspects of ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 3Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Study Links Biomechanics and Gene Expression in Stem Cells 2
... an online application provider, have won the 2006 "Creating ... Claire Area Economic Development Corp . , ,Winners in ... LLC, an online application service provider of real estate ... of multi-oil combustion systems. , ,In addition to recognition, ...
... - In a move designed to give Wisconsin a ... announced a partnership agreement with the Wisconsin Alumni ... cell research at non-profit and academic institutions in Wisconsin ... patents held by WARF. , ,In what the administration ...
... esoteric territory, but a Madison court is taking some of ... might be giving smaller drug companies a chance to defend ... example occurred last month. After a relatively speedy trial that ... District Court for the Western District of Wisconsin first ...
Cached Biology Technology:Eau Claire business contest honors tech start ups 2Doyle, WARF announce partnership to lure stem cell companies 2Doyle, WARF announce partnership to lure stem cell companies 3With patents, Wisconsin court gaining reputation as a "rocket docket" 2With patents, Wisconsin court gaining reputation as a "rocket docket" 3With patents, Wisconsin court gaining reputation as a "rocket docket" 4
(Date:8/1/2014)... the fossil record about 200,000 years ago, but it ... and advanced tools became widespread. , A new ... Anthropology finds that human skulls changed in ways ... the same time that culture was blossoming. , "The ... rapid cultural exchange probably came at the same time ...
(Date:8/1/2014)... research will provide enormous opportunities for both biological ... replicate any other cells in the body, offering ... spinal cords, treating kidney, liver and lung diseases ... profit is staggering. Prof. Jinhui Chen from Indiana ... research still faces myriad biological, ethical, legal, political, ...
(Date:8/1/2014)... soon have a more effective way to control the ... from the National University of Singapore (NUS). , The ... Department of Pharmacology at the NUS Yong Loo Lin ... a recent PhD graduate from the Saw Swee Hock ... a common herbal-based anti-malarial drug, can be used to ...
Breaking Biology News(10 mins):Society bloomed with gentler personalities and more feminine faces 2NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2
... The Center for Alternatives to Animal Testing (CAAT) at ... the National Academy of Sciences (NAS) and the authors of ... Vision and a Strategy, to receive the CAAT Recognition Award ... the 7th World Congress on Alternatives and Animal Use in ...
... thing that comes to mind when people think of Alzheimer,s ... Korea and France, this might change. That,s because these researchers ... "RanBP9" might be the key that unlocks an entirely new ... research report published online in The FASEB Journal ...
... and scientists need an informed, thoughtful, and open-minded citizenry. ... is strikingly inconsistent with the low level of scientific ... the "Year of Science," professional scientific organizations and grassroots, ... focus on the importance of science now and in ...
Cached Biology News:Scientists begin to untangle root cause of Alzheimer's disease 2How to advance scientific literacy 2How to advance scientific literacy 3
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Biology Products: